Tripelennamine
Back to searchScientific Name: | Tripelennamine |
Brand Name: | Not Available |
Company Owner: | Novartis pharmaceuticals corp, Anabolic inc, Barr laboratories inc, Heather drug co inc, Impax laboratories inc, Lannett co inc, Nylos trading co inc, Parke davis div warner lambert co, Watson laboratories inc |
Mechanism Of Action | Tripelennamine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. |
Description of the Drug: | Tripelennamine is a histamine H1 antagonist used to treat hypersensitivity reactions, coughs, and the common cold. |
Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00792